id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-319022-1twsxzcd	Desai, Antonio	The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy()	2020-09-25		.txt	text/plain	2874	83	34	JAMA The 2019 coronavirus: Learning curves, lessons, and the weakest link World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects World Health O. when COVID-19 disease is suspected: interim guidance Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19 Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial Indication, Timing, and Surgical Treatment of Spontaneous Intracerebral Hemorrhage: Systematic Review and Proposal of a Management Algorithm Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy -Thromb Res We would like to thank and dedicate this paper to all the professional A retrospective, observational study in Northern Italy() date: 2020-09-25 journal: Int J Cardiol DOI: 10.1016/j.ijcard.2020.09.062 sha: doc_id: 319022 cord_uid: 1twsxzcd BACKGROUND: There is a great deal of debate about the role of cardiovascular comorbidities and the chronic use of antihypertensive agents (such as ACE-I and ARBs) on mortality on COVID-19 patients.	cache/cord-319022-1twsxzcd.txt	txt/cord-319022-1twsxzcd.txt
